Brief: Nkarta Inc Clinical Data From Ntrust-1 And Ntrust-2 Planned For 2025
05/12/2024 11:22
Dec 5 (Reuters) - Nkarta NKTX.O :
* NKARTA ANNOUNCES IND CLEARANCE OF INVESTIGATOR-SPONSORED
TRIAL
IN MYASTHENIA GRAVIS AND OPENING OF ENROLLMENT FOR NTRUST-2
* NKARTA INC: CLINICAL DATA FROM NTRUST-1 AND NTRUST-2
PLANNED FOR
2025
Source text: ID:nGNX74qBtf
Further company coverage: NKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nkarta
See all newsNkarta, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biotech firm Nkarta posts Q2 net loss; cash runway into 2029
Brief: Nkarta Q2 EPS USD -0.54
Nkarta, Inc. expected to post a loss of 38 cents a share - Earnings Preview
Biotech experts want FDA drug reviews based on science, not politics (updated)